GoLYTELY
NDC 52268-100, Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride, powder, for solution, from Braintree Laboratories, Inc..
- Product NDC
- 52268-100
- Status
- Listed
- Labeler
- Braintree Laboratories, Inc.
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA019011
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52268-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POLYETHYLENE GLYCOL 3350236 g/4L
- SODIUM SULFATE ANHYDROUS22.74 g/4L
- SODIUM BICARBONATE6.74 g/4L
- SODIUM CHLORIDE5.86 g/4L
- POTASSIUM CHLORIDE2.97 g/4L
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52268-100-01 | 52268010001 | 4 L in 1 BOTTLE, PLASTIC (52268-100-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/57d22b0b-1ae0-4203-babc-f3bac17bd1c9NADAC price for package 52268010001
GET /v1/drugs/nadac/52268010001
Use it
Look up 52268-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52268-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52268-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.